Patient Centricity and Virtualizing Technologies in a COVID-19 World: Measuring how the pandemic is driving adoption of digital tools in fully virtual, hybrid, and traditional clinical trials.
As the COVID-19 pandemic rages on, clinical trial conduct is being reimagined in ways few thought possible. As all stakeholders rethink how to develop protocols, consent patients, ensure compliance, and gather quality clinical trial data when patients and staff are remote, patient centricity has stepped to the forefront. To quantify this trend, the Society for Clinical Research Sites (SCRS) collaborated with Medidata (a Dassault Systemes Company) to survey and measure current and anticipated levels of adoption of patient-centric tools, and the sites’ perspective on how patients have reacted to them. Counter to expectation, the survey revealed that sites are receptive to virtualizing technologies that facilitate their work while enhancing the patient experience. Inform your technology strategy based on the latest insight.